Product Information

DULOXETINE HCL DR 60 MG CAP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1293 per EA under NDC 67877026590. Its NADAC has been published 347 times since Jan 1, 2020.

FDA first approved this application on Aug 26, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DULOXETINE HCL DR 60 MG CAP

Duloxetine
$0.1293per EA

Strength

60 mg/1

NDC

67877026590

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DULOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203197

FDA Approved

8/26/2015

TE Code

AB

On Market Since

5/1/2012

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DULOXETINE HCL DR 60 MG CAP has been published 347 times since Jan 1, 2020, and over the history we have for it it has declined 18.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1293 per EA
All-time high$0.1723 (Jul 15, 2020)
All-time low$0.0840 (Nov 20, 2024)
52-week high$0.1306
52-week low$0.0929
Median price$0.1158
Average price$0.1222
Largest weekly change-22.1% (Nov 17, 2021)
Weeks tracked347
Tracking sinceJan 1, 2020

Price History

1W

+0.2%

1M

+0.2%

3M

-1.0%

6M

+26.3%

1Y

+34.4%

3Y

+15.9%

5Y

-1.4%

All

-18.6%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DULOXETINE HCL DR 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 60 MG CAP, manufactured by Ascend Laboratories, LLC, is $0.1293 per EA (NDC 67877026590), effective Aug 19, 2026.

How has the price of DULOXETINE HCL DR 60 MG CAP changed over time?

Over the history we have for it, the NADAC for DULOXETINE HCL DR 60 MG CAP has declined 18.6%. It has been tracked across 347 weekly CMS publications since Jan 1, 2020.

What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 60 MG CAP?

Since Jan 1, 2020, the NADAC for DULOXETINE HCL DR 60 MG CAP has ranged from a low of $0.0840 (Nov 20, 2024) to a high of $0.1723 (Jul 15, 2020), with a median of $0.1158 per EA.

Are there cheaper alternatives to DULOXETINE HCL DR 60 MG CAP?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 60 MG CAP, is $0.1072 per EA — about 17% below DULOXETINE HCL DR 60 MG CAP.

Who manufactures DULOXETINE HCL DR 60 MG CAP?

DULOXETINE HCL DR 60 MG CAP (NDC 67877026590) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.